KIT and cancer: Once the importance of emerging genetic alternations is established in these cancers, such asMET amplifications,ROS1 andRET rearrangements, andHER2 mutations, the OncoFOCUSTM+KIT screening panel could be expanded to facilitate more complete molecular diagnosis.